Per Artikel

Riset dan Pengabdian Masyarakat Do Research Sosial Service and Innovation

Id	Authors	Full Names	Author S Id	Title	Year	Source Title	Page Start	Page End	Page Count	Cited By	Link	Affiliations	Authors With Affiliations	Abstract	Author Keywords	Index Keywords	Funding Details	Funding Text	Publisher	Issn	Isbn	Document Type	Sjr Best Quartile	Sjr	Sjr Rank
Display # Page 1 of 50 Start Prev 1 2 3 4 5 6 7 8 9 10 Next End
(10)
No records
202	La Distia Nora R.; Putera I.; Schrijver B.; Singh G.; Bakker M.; Riasanti M.; Edwar L.; Susiyanti M.; Aziza Y.; ten Berge J.C.E.M.; Rombach S.M.; van Hagen P.M.; Sitompul R.; Dik W.A.	La Distia Nora, Rina (56001881000); Putera, Ikhwanuliman (56485949000); Schrijver, Benjamin (36345029700); Singh, Gurmeet (57209127647); Bakker, Marleen (7101722384); Riasanti, Mei (57565527600); Edwar, Lukman (55695047800); Susiyanti, Made (19640377300); Aziza, Yulia (57214455776); ten Berge, Josianne C.E.M. (56601233400); Rombach, Saskia M. (58860662800); van Hagen, P. Martin (57210765646); Sitompul, Ratna (8312163900); Dik, Willem A. (6603280038)	56001881000; 56485949000; 36345029700; 57209127647; 7101722384; 57565527600; 55695047800; 19640377300; 57214455776; 56601233400; 58860662800; 57210765646; 8312163900; 6603280038	Ocular Tuberculosis Diagnosis Through Biomarkers: Clinical Relevance of Serum C1q and Whole Blood Interferon Gene Signature Score	2024	Ocular Immunology and Inflammation				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196720125&doi=10.1080%2f09273948.2024.2368670&partnerID=40&md5=90e9ebb4b8293b16143edf21e828102d	Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Internal Medicine Section Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Respirology and Critical Illness Division, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, Netherlands	La Distia Nora R., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Putera I., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Internal Medicine Section Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Schrijver B., Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Singh G., Department of Internal Medicine, Respirology and Critical Illness Division, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Bakker M., Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, Netherlands; Riasanti M., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Edwar L., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Susiyanti M., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Aziza Y., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; ten Berge J.C.E.M., Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; Rombach S.M., Department of Internal Medicine Section Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; van Hagen P.M., Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Internal Medicine Section Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Sitompul R., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Dik W.A., Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands	Purpose: To assess the clinical relevance of pathophysiology-based biomarkers, specifically serum C1q and whole blood interferon gene signature score (IGSS), in ocular tuberculosis (OTB) diagnosis by conducting an integrative analysis of clinical presentations and treatment response. Methods: This retrospective cohort study analysed data from 70 patients with suspected OTB at a tertiary care uveitis practice in Indonesia. Serum C1q levels and whole blood IGSS were quantified. Patients were categorized into four quadrants based on their biomarker profiles: quadrant 1 (high C1q & low IGSS), quadrant 2 (high C1q & high IGSS), quadrant 3 (low C1q & high IGSS), and quadrant 4 (low C1q & low IGSS). Characteristics of clinical presentations, work-up results, and treatment outcomes were explored according to the predefined quadrants. Results: We identified that the majority of OTB patients diagnosed with concurrent active pulmonary TB were in quadrant 1, 2, or 3 (20/23, 87.0%). Twenty-seven patients (27/47, 57.4%) with clinically undifferentiated uveitis were in quadrant 4 (p < 0.001). Among patients in quadrants 1, 2, and 3, completion of a full course of antitubercular treatment (ATT) was associated with a lower number of patients showing persistence or recurrence of ocular inflammation compared to those who were not fully treated with ATT (14.3% vs 85.7%, p = 0.001). Conclusions: Based on the analysis of clinical features and treatment outcomes, patients with elevated levels of either or both serum C1q and whole blood IGSS may reflect active TB disease in the eye, necessitating full ATT management. © 2024 Taylor & Francis Group, LLC.	Biomarker; C1q; diagnosis; ocular tuberculosis; type 1 interferon				Taylor and Francis Ltd.	09273948		Article	Q1	805	5924	View
205	Ambarsari C.G.; Tandri C.C.; Situmorang G.R.	Ambarsari, Cahyani Gita (57211850895); Tandri, Chika Carnation (58612308600); Situmorang, Gerhard Reinaldi (57190001213)	57211850895; 58612308600; 57190001213	Urinary extracellular vesicles: Potential biomarkers for vesicoureteral reflux	2024	Vesicoureteral Reflux: From Diagnosis to Treatment	1	31	30	0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85188558589&partnerID=40&md5=8a9d50d7da10ee591511aac119604866	Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Child Health, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; University of Nottingham, Nottingham, United Kingdom; Medical Technology Cluster, Indonesian Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Urology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia	Ambarsari C.G., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Child Health, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, University of Nottingham, Nottingham, United Kingdom, Medical Technology Cluster, Indonesian Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Tandri C.C., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Situmorang G.R., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Urology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia	Vesicoureteral reflux (VUR) is characterized by the backward flow of urine from the bladder to the upper urinary tract, causing kidney damage if left untreated. However, the current diagnostic method, voiding cystourethrography (VCUG), is invasive, potentially risky, and may cause anxiety, especially for young patients and their caregivers. Urinary extracellular vesicles (uEVs) are small vesicles originating from the renal tubular system that carry lipids, proteins, and RNAs for intercellular communication and regulation. uEVs have emerged as promising human biofluid-derived biomarkers in various kidney diseases. This chapter explores the potential of uEVs as noninvasive biomarkers for diagnosing VUR, monitoring its progression, and determining the extent of kidney damage. Previously, serum inflammatory markers have been identified as factors associated with kidney fibrosis in reflux nephropathy, but these may simply be a reflection of systemic inflammation rather than of a specific condition. Meanwhile, current research on uEVs in VUR remains limited. One study has identified vitronectin, a uEV-derived protein, as a predictor of VUR induced by spinal cord injury (sensitivity = 80%, specificity = 82.9%, area under the curve (AUC) = 0.795). Another study, focusing on pediatric VUR, showed that patients with kidney fibrosis had significantly higher urinary neutrophil gelatinaseassociated lipocalin (uNGAL) values than those without kidney fibrosis (1.49 ng/mL vs. 0.58 ng/mL, p < 0.001). However, apart from kidney fibrosis, uNGAL also increases in the contexts of AKI and pediatric urinary tract infections, indicating that uNGAL is not specific as a single marker for VUR. These findings highlight the importance of identifying biomarkers derived from entities, such as uEVs, that are specific to the urinary system and are not affected by systemic factors In summary, uEVs offer crucial insights into urinary tract processes and have broad potential for diagnosing, treating, and forecasting kidney and urinary tract diseases, including VUR. Future studies to test their role should encompass larger sample sizes, standardized protocols, and rigorous validation. © 2024 Nova Science Publishers, Inc. All rights reserved.	Diagnostic; Fibrosis; Invasive; Kidney damage; Urinary tract				Nova Science Publishers, Inc.		979-889113505-5; 979-889113444-7	Book chapter	#N/A	#N/A	#N/A	View
299	Putera I.; Widodo E.; Riasanti M.; Waliyuddin M.Z.; Sitompul R.; Edwar L.; Susiyanti M.; Aziza Y.; Yasmon A.; van Hagen P.M.; La Distia Nora R.	Putera, Ikhwanuliman (56485949000); Widodo, Erica (59185550500); Riasanti, Mei (57565527600); Waliyuddin, Muhammad Zakiy (58244390800); Sitompul, Ratna (8312163900); Edwar, Lukman (55695047800); Susiyanti, Made (19640377300); Aziza, Yulia (57214455776); Yasmon, Andi (41462004500); van Hagen, P. Martin (57210765646); La Distia Nora, Rina (56001881000)	56485949000; 59185550500; 57565527600; 58244390800; 8312163900; 55695047800; 19640377300; 57214455776; 41462004500; 57210765646; 56001881000	Ocular tuberculosis with Mycobacterium tuberculosis DNA presence in ocular fluid: will post-COVID era bring a difference?	2024	Eye (Basingstoke)				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196703102&doi=10.1038%2fs41433-024-03200-3&partnerID=40&md5=64b2c7e490291a5d370ca67e7e998b82	Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Section Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Microbiology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia	Putera I., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Internal Medicine, Section Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Widodo E., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Riasanti M., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Waliyuddin M.Z., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Sitompul R., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Edwar L., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Susiyanti M., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Aziza Y., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Yasmon A., Department of Microbiology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; van Hagen P.M., Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Internal Medicine, Section Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; La Distia Nora R., Department of Ophthalmology, Faculty of Medicine, University of Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands	[No abstract available]			Riset Inovatif Produktif; Lembaga Pengelola Dana Pendidikan, LPDP; RISPRO LPDP, (RISPRO/KI/B1/KOM/5/15219/4/2020)	This study was supported by Riset Inovatif Produktif - Lembaga Pengelola Dana Pendidikan (RISPRO LPDP) [grant number RISPRO/KI/B1/KOM/5/15219/4/2020]. The funding source was not involved in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the article for publication.	Springer Nature	0950222X		Article	#N/A	#N/A	#N/A	View
301	Grijsen M.L.; Hamers R.L.	Grijsen, Marlous L. (25225113700); Hamers, Raph L. (23034345900)	25225113700; 23034345900	Scombroid fish poisoning	2024	JEADV Clinical Practice				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190415283&doi=10.1002%2fjvc2.414&partnerID=40&md5=da875391670703c7d8c657e6945f6d38	Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom	Grijsen M.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom; Hamers R.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom	[No abstract available]	mackerel; Scombridae; scombroid fish poisoning; skin rash; toxin-induced; tuna				John Wiley and Sons Inc	27686566		Note	#N/A	#N/A	#N/A	View
313	Wahono C.S.; Pratama M.Z.; Rahman P.A.; Halim E.N.; Pranawa F.J.; Aditya J.; Rahmawati L.D.; Yuliasih; Awalia; Sylvawani M.; Musdalita E.; Marpaung B.; Ginting A.R.; Partan R.U.; Darma S.; Najirman; Anggoro S.; Parlindungan F.; Hidayat R.; Langow S.S.; Nurudhin A.; Werdiningsih Y.; Kertia N.; Wachid D.N.; Paramaiswari A.; Suntoko B.; Helmi R.Y.; Warlisti I.V.; Dewi S.; Hamijoyo L.; Rahmadi A.R.; Kambayana G.; Kurniari P.K.; Suarjana I.N.; Ongkowijaya J.A.; Faridin; Adnan E.; Syahriani F.	Wahono, Cesarius Singgih (56005807700); Pratama, Mirza Zaka (56993540600); Rahman, Perdana Aditya (57226529432); Halim, Evelyne Naftali (58999823400); Pranawa, Ferrisaga Jetha (58999381300); Aditya, Juan (58998935500); Rahmawati, Lita Diah (57207854957); Yuliasih (57209452044); Awalia (57207854647); Sylvawani, Mahriani (57225078775); Musdalita, Eva (57477601800); Marpaung, Blondina (57192888311); Ginting, Andi Raga (57215378335); Partan, Radiyati Umi (57190664693); Darma, Surya (58155856100); Na	56005807700; 56993540600; 57226529432; 58999823400; 58999381300; 58998935500; 57207854957; 57209452044; 57207854647; 57225078775; 57477601800; 57192888311; 57215378335; 57190664693; 58155856100; 58866983800; 58998786800; 57216245906; 37067327300; 56483271700; 57194509488; 57221595198; 55353578100; 58998786900; 57203663712; 57216431307; 58999233800; 58606578600; 57212522233; 25936059700; 57211655175; 57219746061; 57371164900; 57215274468; 58865874100; 58998935600; 56780398200; 58999674400	Assessment of the public knowledge, perception and attitude in Indonesia toward spondyloarthritis: a national survey	2024	International Journal of Health Promotion and Education				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191149079&doi=10.1080%2f14635240.2024.2337733&partnerID=40&md5=ebbdca728add772ed3869179f26a1d68	Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga, Dr Soetomo General Hospital, Surabaya, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sumatera Utara, Medan, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sriwijaya, Mohammad Hoesin General Hospital, Palembang, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Andalas, Padang, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; Department of Internal Medicine, Siloam Hospital Lippo Vilage, Jakarta, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sebelas Maret, Dr Moewardi General Hospital, Solo, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada, Yogyakarta, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Diponegoro, Dr Kariadi General Hospital, Semarang, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Lambung Mangkurat, Banjarmasin, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Hasanudin, Makassar, Indonesia	Wahono C.S., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Pratama M.Z., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Rahman P.A., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Halim E.N., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Pranawa F.J., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Aditya J., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Rahmawati L.D., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga, Dr Soetomo General Hospital, Surabaya, Indonesia; Yuliasih, Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga, Dr Soetomo General Hospital, Surabaya, Indonesia; Awalia, Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga, Dr Soetomo General Hospital, Surabaya, Indonesia; Sylvawani M., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh, Indonesia; Musdalita E., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Syiah Kuala, Banda Aceh, Indonesia; Marpaung B., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sumatera Utara, Medan, Indonesia; Ginting A.R., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sumatera Utara, Medan, Indonesia; Partan R.U., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sriwijaya, Mohammad Hoesin General Hospital, Palembang, Indonesia; Darma S., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sriwijaya, Mohammad Hoesin General Hospital, Palembang, Indonesia; Najirman, Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Andalas, Padang, Indonesia; Anggoro S., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; Parlindungan F., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; Hidayat R., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia; Langow S.S., Department of Internal Medicine, Siloam Hospital Lippo Vilage, Jakarta, Indonesia; Nurudhin A., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sebelas Maret, Dr Moewardi General Hospital, Solo, Indonesia; Werdiningsih Y., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Sebelas Maret, Dr Moewardi General Hospital, Solo, Indonesia; Kertia N., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada, Yogyakarta, Indonesia; Wachid D.N., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada, Yogyakarta, Indonesia; Paramaiswari A., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada, Yogyakarta, Indonesia; Suntoko B., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Diponegoro, Dr Kariadi General Hospital, Semarang, Indonesia; Helmi R.Y., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Diponegoro, Dr Kariadi General Hospital, Semarang, Indonesia; Warlisti I.V., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Diponegoro, Dr Kariadi General Hospital, Semarang, Indonesia; Dewi S., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Hamijoyo L., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Rahmadi A.R., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Kambayana G., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia; Kurniari P.K., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia; Suarjana I.N., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Lambung Mangkurat, Banjarmasin, Indonesia; Ongkowijaya J.A., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Lambung Mangkurat, Banjarmasin, Indonesia; Faridin, Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Hasanudin, Makassar, Indonesia; Adnan E., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Hasanudin, Makassar, Indonesia; Syahriani F., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Hasanudin, Makassar, Indonesia	Lack of public awareness of spondyloarthritis (SpA) leads to diagnosis delay and high disease activity. This study aimed to assess the public knowledge, perceptions, and attitudes towards SpA in Indonesia. This research was a cross-sectional study with an online questionnaire. A total of 1084 participants’ demographics, knowledge, attitude, and perception of SpA were obtained using convenience sampling. Respondents’ knowledge, attitude, and perception levels were scored numerically and categorized (satisfactory and unsatisfactory). Associations were assessed using a logistic regression analysis. The mean ± standard deviation (SD) knowledge score was 5.21 ± 1.89 (45.11% of respondents had satisfactory knowledge). Living on Java Island was associated with the participants’ unsatisfactory knowledge (Adjusted Odds Ratio (AOR): 1.33; 95% confidence interval (CI): 1.03 to 1.71; p = 0.027). The mean ± SD perception score was 3.14 ± 1.21 (35.98% of respondents had a satisfactory perception). Education (bachelor AOR: 1.46; 95% CI 1.08 to 1.98; p = 0.014) and occupation (employed AOR: 1.53; 95% CI: 1.07 to 2.20; p = 0.020) were significantly associated with poor perception. The mean ± SD score of attitudes was 2.52 ± 1.54, while only 54.24% of participants preferred went to the doctor if they had symptoms of SpA. Employed respondents (AOR: 1.40; 95% CI: 1.07 to 2.01; p = 0.046) and living inside Java Island (AOR: 1.45; 95% CI: 1.13 to 1.87; p = 0.004) were associated with attitudes towards SpA. In conclusion, more than half of the subjects had a poor knowledge, perception, or attitude towards SpA. Therefore, programs that empower the knowledge, attitude, and perception towards SpA in community need to be developed to close this gap. © 2024 Institute of Health Promotion and Education.	attitude; Knowledge; perception; spondyloarthritis		Universitas Brawijaya, UB	Authors thank to all the members from the Indonesian Rheumatology Association (IRA) for the contribution of this study. Authors also thank all the physicians and residents that helped the sampling of the patients in this study. This study was supported by the 3in1 program of the Universitas Brawijaya in 2022.	Routledge	14635240		Article	Q3	358	13485	View
320	Manurung M.A.; Umbas R.; Hamid A.R.A.H.; Mochtar C.A.	Manurung, Mega Anara (58293043000); Umbas, Rainy (6602634832); Hamid, Agus Rizal A. H. (57202054669); Mochtar, Chaidir Arif (6506558321)	58293043000; 6602634832; 57202054669; 6506558321	Penile carcinoma: A retrospective analysis of 93 patients at a tertiary care center in Jakarta, Indonesia	2024	International Journal of Urology				2	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190892282&doi=10.1111%2fiju.15462&partnerID=40&md5=5701ee106fc9c117e0f66595713264e8	Department of Urology, Faculty of Medicine/Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia	Manurung M.A., Department of Urology, Faculty of Medicine/Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Umbas R., Department of Urology, Faculty of Medicine/Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Hamid A.R.A.H., Department of Urology, Faculty of Medicine/Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Mochtar C.A., Department of Urology, Faculty of Medicine/Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia	Objectives: Penile carcinoma (PC) is a rare disease with considerable physical and psychological impact. To date, there is no data regarding PC prevalence and characteristics in Indonesia. This study aimed to analyze the characteristics of patients with PC in Indonesia and determine cumulative survival rates and time to disease progression. Methods: This was a retrospective study of all patients diagnosed with PC at Cipto Mangunkusumo General Hospital from 1995 to 2014, with a minimum of 1 year follow-up. The outcomes of the study were cumulative survival rates and time-to-disease progression. Results: Ninety-three subjects were recruited, with a mean age of 49.44 ± 13.62. Inguinal lymph node dissection (ILND) was performed in 49 (53%) patients. The mean survival in the ILND group was better compared to the non-ILND group (80.7 months vs. 67.1 months; p = 0.032). Time-to-progression in the ILND group was significantly longer than in the non-ILND group (71.7 months vs. 54.3 months; p = 0.022). No significant difference in survival between the total and partial penectomy (PP) groups was observed (p = 0.701). Time-to-progression in total penectomy (TP) was significantly longer than in PP (68 months vs. 56.0 months; p = 0.023). In Cox-regression analysis, after adjustment of other variables, history of ILND, higher stage of cancer, and older age were found to affect the survival of patients. Conclusion: ILND in PC led to better survival and reduced disease progression. The type of penectomy is only associated with progression but not survival. TP had a longer time to disease progression compared to PP. © 2024 The Japanese Urological Association.	inguinal lymph node dissection; penectomy; penile cancer; the survival rate; time to disease progression				John Wiley and Sons Inc	09198172		Article	Q2	694	7174	View
324	Sihombing U.H.M.; Andrijono A.; Purwoto G.; Gandamihardja S.; Harahap A.R.; Rustamadji P.; Kekalih A.; Widyawati R.; Fuady D.R.	Sihombing, Unedo Hence Markus (57741696900); Andrijono, Andrijono (36704391000); Purwoto, Gatot (14720170400); Gandamihardja, Supriadi (54880603300); Harahap, Alida R. (6507325543); Rustamadji, Primariadewi (55321572200); Kekalih, Aria (55633562200); Widyawati, Retno (57212476754); Fuady, Dzicky Rifqi (57198896312)	57741696900; 36704391000; 14720170400; 54880603300; 6507325543; 55321572200; 55633562200; 57212476754; 57198896312	Correction to: Cancer Stem Cells (CD44+/CD24−), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer Chemoresistance (The Journal of Obstetrics and Gynecology of India, (2023), 10.1007/s13224-023-01829-w)	2024	Journal of Obstetrics and Gynecology of India				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189788762&doi=10.1007%2fs13224-024-01987-5&partnerID=40&md5=ea45b0735afda5c35232009843461a80	Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia; Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Hasan Sadikin Hospital, Universitas Padjadjaran, Bandung, Indonesia; Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Occupational Medicine Division, Community Medicine Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Anatomic Pathology, Budhi Asih Hospital, Jakarta, Indonesia; Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Department of Obstetrics and Gynecology, Karawang General Public Hospital, Karawang, Indonesia; Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Sihombing U.H.M., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia, Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Andrijono A., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Purwoto G., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Gandamihardja S., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Hasan Sadikin Hospital, Universitas Padjadjaran, Bandung, Indonesia; Harahap A.R., Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Rustamadji P., Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Kekalih A., Occupational Medicine Division, Community Medicine Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Widyawati R., Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Department of Anatomic Pathology, Budhi Asih Hospital, Jakarta, Indonesia; Fuady D.R., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia, Department of Obstetrics and Gynecology, Karawang General Public Hospital, Karawang, Indonesia	The graphical abstract published in the earlier version of the article has been removed. It was an inadvertent error occurred at the production stage and unfortunately overlooked during the successive correction stages as well. The original article has been corrected. © Federation of Obstetric & Gynecological Societies of India 2024.		adult; cancer stem cell; drug resistance; drug therapy; erratum; female; human; immunohistochemistry; ovary cancer; scoring system			Springer	09719202		Erratum	Q3	286	15584	View
332	Wu E.B.; Kalyanasundaram A.; Brilakis E.S.; Mashayekhi K.; Tsuchikane E.; Rafeh N.A.; Agostoni P.; Alaswad K.; Araya M.; Avran A.; Ayoub M.; Azzalini L.; Babunashvili A.M.; Bayani B.; Behnes M.; Bhindi R.; Boudou N.; Boukhris M.; Bozinovic N.Z.; Bryniarski L.; Bufe A.; Buller C.E.; Burke M.N.; Buettner H.J.; Cardoso P.; Carlino M.; Chan C.-K.; Chen J.; Christiansen E.H.; Colombo A.; Croce K.; Damas de los Santos F.; de Martini T.; Dens J.; di Mario C.; Doshi D.; Dou K.; Egred M.; Elbarouni B.; ElGuindy A.M.; Escaned J.; Furkalo S.; Gagnor A.; Galassi A.R.; Garbo R.; L.Gasparini G.; Ge J.; Ge L.; Goel P.K.; Goktekin O.; Gonzalo N.; Gorgulu S.; Grancini L.; Hall A.B.; Hanratty C.; Harb S.; Harding S.A.; Hatem R.; Hellig F.; Henriques J.P.S.; Hildick-Smith D.; Hill J.M.; Hoye A.; Jaber W.; Jaffer F.A.; Jang Y.; Jussila R.; Kalnins A.; Kalra S.; Kandzari D.E.; Kao H.-L.; Karmpaliotis D.; Kassem H.H.; Kearney K.E.; Kerrigan J.; Khatri J.; Khelimskii D.; Kirtane A.J.; Knaapen P.; Kornowski R.; Krestyaninov O.; Kumar V.G.; Kumar P.; Lamelas P.M.; Lee S.-W.; Lefevre T.; Leibundgut G.; Leung R.; Leung S.-K.; Li Y.; Li Y.; Lim S.-T.; Lo S.; Lombardi W.; Maran A.; McEntegart M.; Moses J.; Munawar M.; Nagamatsu W.; Navarro A.; Ngo H.M.; Nicholson W.; Oksnes A.; Olivecrona G.K.; Padilla L.; Patel M.; Pershad A.; Postu M.; Pyxaras S.; Qian J.; Quadros A.; Hanna Quesada F.L.; Råmunddal T.; Rao V.S.; Rathore S.; Reifart N.; Riley R.F.; Rinfret S.; Saghatelyan M.; Santiago R.; Seth A.; Sianos G.; Smith E.; Spaedy A.; Spratt J.; Stone G.W.; Strange J.W.; Tammam K.O.; Thompson C.A.; Toma A.; Tremmel J.A.; Ungi I.; Vadalà G.; Vo M.; Vu V.H.; Walsh S.; Weilenmann D.; Werner G.S.; Wojcik J.; Wollmuth J.; Wu C.-J.; Xu B.; Yamane M.; Ybarra L.F.; Yeh R.W.; Zambakides C.; Zhang Q.	Wu, Eugene B. (9234022900); Kalyanasundaram, Arun (15044594400); Brilakis, Emmanouil S. (6701693111); Mashayekhi, Kambis (36915264400); Tsuchikane, Etsuo (7004090536); Rafeh, Nidal Abi (35271217100); Agostoni, Pierfrancesco (57226223987); Alaswad, Khaldoon (6505946630); Araya, Mario (36125909000); Avran, Alexandre (57191835867); Ayoub, Mohamed (57055208800); Azzalini, Lorenzo (16300760500); Babunashvili, Avtandil M. (6603588183); Bayani, Baktash (36112736500); Behnes, Michael (24175917200); Bhin	9234022900; 15044594400; 6701693111; 36915264400; 7004090536; 35271217100; 57226223987; 6505946630; 36125909000; 57191835867; 57055208800; 16300760500; 6603588183; 36112736500; 24175917200; 57203195611; 25644193800; 55771360100; 56614042000; 6701830118; 7003940019; 7005611133; 7402868324; 7102293284; 56498701800; 6603766324; 59155104400; 7501881901; 59154769200; 35354455800; 6602373657; 36451940200; 6507441146; 59154436100; 7101723312; 56511612400; 14059806100; 13006459000; 24340486800; 56631052000; 56517095000; 56561054300; 57208183057; 7004438532; 6506467751; 59155104500; 57683436300; 55429799000; 7101942299; 7003402250; 24484668300; 56209450200; 6602258753; 57204447163; 55813173400; 6701334083; 7202447753; 35721997800; 36949118500; 56241710300; 8089365300; 55652210200; 55167799300; 8847051400; 6603908821; 55429942500; 8588323800; 56680930800; 57188839005; 7003465312; 7201431849; 35461263500; 55674926900; 56642519100; 57716082500; 6603058431; 59154094100; 6603083771; 6602836006; 16947378300; 57200584086; 59154769300; 7403961613; 55958468700; 17233718400; 13608617100; 57503426600; 56844820300; 59154603600; 57226704048; 59154770700; 57226702255; 7401542169; 57190795527; 57189630940; 12787521600; 55607974600; 16747447600; 18233908900; 57203315496; 57210443231; 24535139700; 57208573295; 8656313100; 8650273000; 54405153100; 6602083383; 24171461000; 24179362300; 57192202763; 13606417300; 57217993296; 12040029100; 59154265600; 22235271400; 8088718100; 36097159500; 6603444680; 24482001100; 57210446049; 7103146364; 7003691774; 7408612732; 6507039495; 35597798500; 7202761439; 7006073350; 36176507300; 7404238092; 55856263600; 8295981700; 6602555341; 57203403924; 55216966500; 57348947900; 7202682240; 57212235322; 7202099557; 7102180606; 9736657700; 59155105500; 59154095700; 36783291300; 25655495600; 14010649400; 16752588300; 59059252000	Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions	2024	Heart Lung and Circulation				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195059905&doi=10.1016%2fj.hlc.2023.11.030&partnerID=40&md5=3643cd3d38318cbb1c8b56d8a4d10a72	Prince of Wales Hospital, Chinese University Hong Kong, Hong Kong; Promed Hospital, Chennai, India; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN, United States; Department of Cardiology and Angiology, II University Heart Center, Freiburg Bad Krozingen, Germany; Toyohashi Heart Center, Aichi, Japan; St. George Hospital University Medical Center, Beirut, Lebanon; NorthOaks Health System, Hammond, LA, United States; HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp, Belgium; Edith and Benson Ford Heart and Vascular Institute, Henry Ford Hospital, Henry Ford Health System, Wayne State University, MI, United States; Clinica Alemana and Hospital Militar de Santiago, Chile; Centre Hospitalier de Valenciennes, Valenciennes, France; University Heartcenter NRW, Bad Oeynhausen, Germany; Division of Cardiology, VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States; Moscow State Medical [Sechenov's] University, Moscow, Russian Federation; Cardiology Department, Mehr Hospital, Mashhad, Iran; First Department of Medicine, University Medical Centre Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, Germany; Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australia; Interventional Cardiology Clinique Saint Augustin Bordeaux France, France; Cardiology Department, CHU Dupuytren, Limoges, France; University Clinical Center of Nis. Serbia, Serbia; Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College; Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland; Heart Center Krefeld, University Witten/Herdecke, Witten, Germany; Teleflex Inc. and St. Michael's Hospital, Toronto, Canada; Department of Cardiology and Angiology, II University Heart Center Freiburg Bad Krozingen, Germany; Cardiology and Vascular Department, Santa Maria University Hospital [CHULN], Lisbon Academic Medical Centre [CAML]; Centro Cardiovascular da Universidade de Lisboa [CCUL], Portugal; Interventional Cardiology Unit, Cardio-Thoracic-Vascular Department IRCCS San Raffaele Scientific Institute, Milan, Italy; Premier Medical Centre, Hong Kong; Guangdong Provincial People's Hospital, Guangdong, China; Department of Cardiology, Aarhus University Hospital, Denmark; Department of Biomedical Sciences, Humanitas University, Pieve Emauele-Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano-Milan, Italy; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, United States; Instituto Nacional de Cardiologia; Ignacio Chávez and Centro Medico ABC, Mexico City, Mexico; Springfield Memorial Hospital, Springfield, IL; Midwest Cardiovascular Institute, Naperville, IL, United States; Hospital Oost-Limburg, Genk, Belgium; Department of Clinical & Experimental Medicine, University Hospital Careggi, Florence, Italy; Massachusetts General Hospital, Boston, MA, United States; Research Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical, China; Freeman Hospital & Newcastle University, Newcastle upon Tyne, United Kingdom; St. Boniface Hospital & University of Manitoba, Winnipeg, MB, Canada; Department of Cardiology, Aswan Heart Centre - Magdi Yacoub Foundation, Egypt; Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain; National Institute of Surgery and Transplantology NAMS, Kiev, Ukraine; Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy; Department of PROMISE University of Palermo, Italy; Maria Pia Hospital, GVM Care & Research Turin, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emauele-Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano-Milan, Italy; Zhongshan Hospital, Fudan University, Shanghai, China; Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Memorial Hospital, Istanbul, Turkey; Interventional Cardiology, Hospital Clinico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain; Acibadem University Cardiology Department, Istanbul, Turkey; Centro Cardiologico Monzino, IRCCS, Milan, Italy; Eastern Health/Memorial University of Newfoundland, St. John's, Newfoundland, Canada; Mater Private Hospital, Dublin, Ireland; Medical University of Graz, Department of Cardiology, University Heart Center, Graz, Austria; Wellington Hospital, Capital and Coast District Health Board, New Zealand; Hôpital du Sacré-Coeur de Montréal Université de Montréal, Canada; Sunninghill Hospital, Johannesburg; Division of Cardiology, University of Cape Town, Cape Town, South Africa; Amsterdam UMC location, University of Amsterdam, Department, Amsterdam, Netherlands; Sussex Cardiac Centre, Brighton, United Kingdom; Royal Brompton Hospital, London, United Kingdom; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, University of Hull, United Kingdom; Emory University, Atlanta, GA, United States; CHA Bundang Medical Center, CHA University College of Medicine, South Korea; Interventional Cardiology, Helsinki Heart Hospital, Finland; Clinic of Cardiovascular Diseases Riga EAST Clinical University Hospital, Riga, Latvia; Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Canada; Piedmont Heart Institute and Cardiovascular Services, Atlanta, GA, United States; Department of Internal Medicine, Cardiology Division, Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ, United States; Kasr Alainy Medical School, Cairo University, Egypt, Fujairah Hospital, Ministry of Health, United Arab Emirates; University of Washington Medical Centre, Seattle, WA, United States; Ascension Saint Thomas Heart, Nashville, TN, United States; Cleveland Clinic, Cleveland, OH, United States; Natsional'nyy Meditsinskiy Issledovatel'skiy Tsentr Imeni Akademika Ye.n. Meshalkina - Novosibirsk, Russian Federation; Columbia University Irving Medical Center, New York, NY, United States; Heart Center of the Amsterdam University Medical Centers, Amsterdam, Netherlands; Department of Cardiology, Rabin Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; E.Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Russian Federation; Department of Cardiology, Dr LH Hiranandani Hospital, Mumbai, India; Meditrina Hospitals Kerala, India; Cardiovascular de Buenos Aires, Argentina; Health Research Methods, Evidence, and Impact, McMaster University, Canada; Department of Cardiology Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea; Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France; Department of Cardiology Medizinische Universitätsklinik Kantonsspital Baselland, Liestal, Switzerland; CK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, AB, Canada; Keen Heart, Hong Kong, Hong Kong; Beijing Anzhen Hospital, Capital Medical University, China; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, China; National Heart Centre of Singapore, Singapore; Department of Cardiology, Liverpool Hospital; The University of New South Wales, Sydney, Australia; University of Washington, Seattle, WA, United States; Medical University of South Carolina Ralph H Johnson VA Medical Center, Charleston, SC, United States; Columbia University Irving Medical Center, New York; St Francis Heart Center, Roslyn, New York, NY, United States; Binawaluya Cardiac Center and Department of Cardiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Cardiology, Faculty of Medicine, Universitas Gadjahmada, Yogyakarta, Indonesia; Hokusetsu General Hospital, Osaka, Japan; QRA Medicina Especilizada, Hospital de los Valles, Universidad San Francisco de Quito, Ecuador; Choray University Hospital, Vietnam, Ho Chi Minh City, Viet Nam; Heart Department, Haukeland University Hospital, Norway; Department of Cardiology SUS-Lund, Lund University, Lund, Sweden; Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina; Division of Cardiovascular Medicine UC San Diego School of Medicine, San Diego, CA, United States; Chandler Regional Medical Center, Chandler, AZ, United States; Cardiology Department, University of Medicine and Pharmacy “Carol Davila,” Institute of Cardiovascular Diseases “Prof. Dr. C.C. Iliescu,” Bucharest, Romania; Medizinische Klinik I, Klinikum Fürth, Fürth, Germany; Beijing Fuwai Hospital, Beijing, China; Interventional Cardiology Division and Post Graduate Course of Cardiology, Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil; The “Clinica Comfamiliar” Pereira, Colombia; Dept of Cardiology Sahlgrenska University Hospital, Gothenburg, Sweden; Hod Cardiology, Care Hospitals Banjara, Telangana, Hyderabad, India; Frimley Health NHS Foundation Trust, Frimley, United Kingdom; Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany; Overlake Medical Center & Clinics, Bellevue, WA, United States; McGill University Health Centre, Montreal, QC, Canada; Nork Marash MC; Erebouni MC, Yerevan, Armenia; PCI Cardiology Group, Bayamon Heart and Lung Institute, Puerto Rico; Fortis Escorts Heart Institute, New Delhi, India; HEPA University Hospital, Thessaloniki, Greece; Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Boone Hospital Center, Columbia, MO, United States; St George's University Hospital NHS Foundation Trust, London, United Kingdom; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Bristol Royal Infirmary, University Hospital Bristol NHS Trust, Bristol, United Kingdom; Department at the International Medical Center, Jeddah, Saudi Arabia; Hartford Healthcare Hartford, CT, United States; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria; Stanford University Medical Centre, Stanford, CA, United States; University of Szeged, Department of Invasive Cardiology, Hungary; Division of Cardiology, University Hospital, Paolo Giaccone, Palermo, Italy; Royal Columbian Hospital, Vancouver, BC, Canada; University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, Viet Nam; Belfast Health and Social Care Trust, Belfast, UK; Boston Scientific, United Kingdom; Department of Cardiology, Kantonsspital St. Gallen, Sankt Gallen, Switzerland; Medizinische Klinik I Klinikum, Darmstadt GmbH, Germany; Hospital of Invasive Cardiology IKARDIA, Nałęczów/Lublin, Poland; Providence Heart and Vascular Institute, Portland, OR, United States; Chang Chung Memorial Hospital, Taiwan; Massachusetts General Hospital Boston, MA, United States; Saitama-Sekishinkai Hospital, Saitama, Japan; London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Department of Cardiology, Chris-Hani Baragwanath Hospital, Johannesburg, South Africa; Shanghai East Hospital, Tongji University, Shanghai, China	Wu E.B., Prince of Wales Hospital, Chinese University Hong Kong, Hong Kong; Kalyanasundaram A., Promed Hospital, Chennai, India; Brilakis E.S., Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN, United States; Mashayekhi K., Department of Cardiology and Angiology, II University Heart Center, Freiburg Bad Krozingen, Germany; Tsuchikane E., Toyohashi Heart Center, Aichi, Japan; Rafeh N.A., St. George Hospital University Medical Center, Beirut, Lebanon; NorthOaks Health System, Hammond, LA, United States; Agostoni P., HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp, Belgium; Alaswad K., Edith and Benson Ford Heart and Vascular Institute, Henry Ford Hospital, Henry Ford Health System, Wayne State University, MI, United States; Araya M., Clinica Alemana and Hospital Militar de Santiago, Chile; Avran A., Centre Hospitalier de Valenciennes, Valenciennes, France; Ayoub M., University Heartcenter NRW, Bad Oeynhausen, Germany; Azzalini L., Division of Cardiology, VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States; Babunashvili A.M., Moscow State Medical [Sechenov's] University, Moscow, Russian Federation; Bayani B., Cardiology Department, Mehr Hospital, Mashhad, Iran; Behnes M., First Department of Medicine, University Medical Centre Mannheim, Faculty of Medicine Mannheim, University of Heidelberg, Germany; Bhindi R., Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australia; Boudou N., Interventional Cardiology Clinique Saint Augustin Bordeaux France, France; Boukhris M., Cardiology Department, CHU Dupuytren, Limoges, France; Bozinovic N.Z., University Clinical Center of Nis. Serbia, Serbia; Bryniarski L., Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College; Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland; Bufe A., Heart Center Krefeld, University Witten/Herdecke, Witten, Germany; Buller C.E., Teleflex Inc. and St. Michael's Hospital, Toronto, Canada; Burke M.N., Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN, United States; Buettner H.J., Department of Cardiology and Angiology, II University Heart Center Freiburg Bad Krozingen, Germany; Cardoso P., Cardiology and Vascular Department, Santa Maria University Hospital [CHULN], Lisbon Academic Medical Centre [CAML]; Centro Cardiovascular da Universidade de Lisboa [CCUL], Portugal; Carlino M., Interventional Cardiology Unit, Cardio-Thoracic-Vascular Department IRCCS San Raffaele Scientific Institute, Milan, Italy; Chan C.-K., Premier Medical Centre, Hong Kong; Chen J., Guangdong Provincial People's Hospital, Guangdong, China; Christiansen E.H., Department of Cardiology, Aarhus University Hospital, Denmark; Colombo A., Department of Biomedical Sciences, Humanitas University, Pieve Emauele-Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano-Milan, Italy; Croce K., Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, United States; Damas de los Santos F., Instituto Nacional de Cardiologia; Ignacio Chávez and Centro Medico ABC, Mexico City, Mexico; de Martini T., Springfield Memorial Hospital, Springfield, IL; Midwest Cardiovascular Institute, Naperville, IL, United States; Dens J., Hospital Oost-Limburg, Genk, Belgium; di Mario C., Department of Clinical & Experimental Medicine, University Hospital Careggi, Florence, Italy; Doshi D., Massachusetts General Hospital, Boston, MA, United States; Dou K., Research Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical, China; Egred M., Freeman Hospital & Newcastle University, Newcastle upon Tyne, United Kingdom; Elbarouni B., St. Boniface Hospital & University of Manitoba, Winnipeg, MB, Canada; ElGuindy A.M., Department of Cardiology, Aswan Heart Centre - Magdi Yacoub Foundation, Egypt; Escaned J., Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain; Furkalo S., National Institute of Surgery and Transplantology NAMS, Kiev, Ukraine; Gagnor A., Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy; Galassi A.R., Department of PROMISE University of Palermo, Italy; Garbo R., Maria Pia Hospital, GVM Care & Research Turin, Italy; L.Gasparini G., Department of Biomedical Sciences, Humanitas University, Pieve Emauele-Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano-Milan, Italy; Ge J., Zhongshan Hospital, Fudan University, Shanghai, China; Ge L., Zhongshan Hospital, Fudan University, Shanghai, China; Goel P.K., Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Goktekin O., Memorial Hospital, Istanbul, Turkey; Gonzalo N., Interventional Cardiology, Hospital Clinico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain; Gorgulu S., Acibadem University Cardiology Department, Istanbul, Turkey; Grancini L., Centro Cardiologico Monzino, IRCCS, Milan, Italy; Hall A.B., Eastern Health/Memorial University of Newfoundland, St. John's, Newfoundland, Canada; Hanratty C., Mater Private Hospital, Dublin, Ireland; Harb S., Medical University of Graz, Department of Cardiology, University Heart Center, Graz, Austria; Harding S.A., Wellington Hospital, Capital and Coast District Health Board, New Zealand; Hatem R., Hôpital du Sacré-Coeur de Montréal Université de Montréal, Canada; Hellig F., Sunninghill Hospital, Johannesburg; Division of Cardiology, University of Cape Town, Cape Town, South Africa; Henriques J.P.S., Amsterdam UMC location, University of Amsterdam, Department, Amsterdam, Netherlands; Hildick-Smith D., Sussex Cardiac Centre, Brighton, United Kingdom; Hill J.M., Royal Brompton Hospital, London, United Kingdom; Hoye A., Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, University of Hull, United Kingdom; Jaber W., Emory University, Atlanta, GA, United States; Jaffer F.A., Massachusetts General Hospital, Boston, MA, United States; Jang Y., CHA Bundang Medical Center, CHA University College of Medicine, South Korea; Jussila R., Interventional Cardiology, Helsinki Heart Hospital, Finland; Kalnins A., Clinic of Cardiovascular Diseases Riga EAST Clinical University Hospital, Riga, Latvia; Kalra S., Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Canada; Kandzari D.E., Piedmont Heart Institute and Cardiovascular Services, Atlanta, GA, United States; Kao H.-L., Department of Internal Medicine, Cardiology Division, Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan; Karmpaliotis D., Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ, United States; Kassem H.H., Kasr Alainy Medical School, Cairo University, Egypt, Fujairah Hospital, Ministry of Health, United Arab Emirates; Kearney K.E., University of Washington Medical Centre, Seattle, WA, United States; Kerrigan J., Ascension Saint Thomas Heart, Nashville, TN, United States; Khatri J., Cleveland Clinic, Cleveland, OH, United States; Khelimskii D., Natsional'nyy Meditsinskiy Issledovatel'skiy Tsentr Imeni Akademika Ye.n. Meshalkina - Novosibirsk, Russian Federation; Kirtane A.J., Columbia University Irving Medical Center, New York, NY, United States; Knaapen P., Heart Center of the Amsterdam University Medical Centers, Amsterdam, Netherlands; Kornowski R., Department of Cardiology, Rabin Medical Center, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Krestyaninov O., E.Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Russian Federation; Kumar V.G., Department of Cardiology, Dr LH Hiranandani Hospital, Mumbai, India; Kumar P., Meditrina Hospitals Kerala, India; Lamelas P.M., Cardiovascular de Buenos Aires, Argentina; Health Research Methods, Evidence, and Impact, McMaster University, Canada; Lee S.-W., Department of Cardiology Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea; Lefevre T., Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France; Leibundgut G., Department of Cardiology Medizinische Universitätsklinik Kantonsspital Baselland, Liestal, Switzerland; Leung R., CK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, AB, Canada; Leung S.-K., Keen Heart, Hong Kong, Hong Kong; Li Y., Beijing Anzhen Hospital, Capital Medical University, China; Li Y., Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, China; Lim S.-T., National Heart Centre of Singapore, Singapore; Lo S., Department of Cardiology, Liverpool Hospital; The University of New South Wales, Sydney, Australia; Lombardi W., University of Washington, Seattle, WA, United States; Maran A., Medical University of South Carolina Ralph H Johnson VA Medical Center, Charleston, SC, United States; McEntegart M., Columbia University Irving Medical Center, New York, NY, United States; Moses J., Columbia University Irving Medical Center, New York; St Francis Heart Center, Roslyn, New York, NY, United States; Munawar M., Binawaluya Cardiac Center and Department of Cardiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Cardiology, Faculty of Medicine, Universitas Gadjahmada, Yogyakarta, Indonesia; Nagamatsu W., Hokusetsu General Hospital, Osaka, Japan; Navarro A., QRA Medicina Especilizada, Hospital de los Valles, Universidad San Francisco de Quito, Ecuador; Ngo H.M., Choray University Hospital, Vietnam, Ho Chi Minh City, Viet Nam; Nicholson W., Emory University, Atlanta, GA, United States; Oksnes A., Heart Department, Haukeland University Hospital, Norway; Olivecrona G.K., Department of Cardiology SUS-Lund, Lund University, Lund, Sweden; Padilla L., Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina; Patel M., Division of Cardiovascular Medicine UC San Diego School of Medicine, San Diego, CA, United States; Pershad A., Chandler Regional Medical Center, Chandler, AZ, United States; Postu M., Cardiology Department, University of Medicine and Pharmacy “Carol Davila,” Institute of Cardiovascular Diseases “Prof. Dr. C.C. Iliescu,” Bucharest, Romania; Pyxaras S., Medizinische Klinik I, Klinikum Fürth, Fürth, Germany; Qian J., Beijing Fuwai Hospital, Beijing, China; Quadros A., Interventional Cardiology Division and Post Graduate Course of Cardiology, Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil; Hanna Quesada F.L., The “Clinica Comfamiliar” Pereira, Colombia; Råmunddal T., Dept of Cardiology Sahlgrenska University Hospital, Gothenburg, Sweden; Rao V.S., Hod Cardiology, Care Hospitals Banjara, Telangana, Hyderabad, India; Rathore S., Frimley Health NHS Foundation Trust, Frimley, United Kingdom; Reifart N., Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany; Riley R.F., Overlake Medical Center & Clinics, Bellevue, WA, United States; Rinfret S., McGill University Health Centre, Montreal, QC, Canada; Saghatelyan M., Nork Marash MC; Erebouni MC, Yerevan, Armenia; Santiago R., PCI Cardiology Group, Bayamon Heart and Lung Institute, Puerto Rico; Seth A., Fortis Escorts Heart Institute, New Delhi, India; Sianos G., HEPA University Hospital, Thessaloniki, Greece; Smith E., Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Spaedy A., Boone Hospital Center, Columbia, MO, United States; Spratt J., St George's University Hospital NHS Foundation Trust, London, United Kingdom; Stone G.W., The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Strange J.W., Bristol Royal Infirmary, University Hospital Bristol NHS Trust, Bristol, United Kingdom; Tammam K.O., Department at the International Medical Center, Jeddah, Saudi Arabia; Thompson C.A., Hartford Healthcare Hartford, CT, United States; Toma A., Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria; Tremmel J.A., Stanford University Medical Centre, Stanford, CA, United States; Ungi I., University of Szeged, Department of Invasive Cardiology, Hungary; Vadalà G., Division of Cardiology, University Hospital, Paolo Giaccone, Palermo, Italy; Vo M., Royal Columbian Hospital, Vancouver, BC, Canada; Vu V.H., University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, Viet Nam; Walsh S., Belfast Health and Social Care Trust, Belfast, UK; Boston Scientific, United Kingdom; Weilenmann D., Department of Cardiology, Kantonsspital St. Gallen, Sankt Gallen, Switzerland; Werner G.S., Medizinische Klinik I Klinikum, Darmstadt GmbH, Germany; Wojcik J., Hospital of Invasive Cardiology IKARDIA, Nałęczów/Lublin, Poland; Wollmuth J., Providence Heart and Vascular Institute, Portland, OR, United States; Wu C.-J., Chang Chung Memorial Hospital, Taiwan; Xu B., Massachusetts General Hospital Boston, MA, United States; Yamane M., Saitama-Sekishinkai Hospital, Saitama, Japan; Ybarra L.F., London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada; Yeh R.W., Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Zambakides C., Department of Cardiology, Chris-Hani Baragwanath Hospital, Johannesburg, South Africa; Zhang Q., Shanghai East Hospital, Tongji University, Shanghai, China	Safety is of critical importance to chronic total occlusion (CTO) percutaneous coronary intervention (PCI). This global consensus statement provides guidance on how to optimise the safety of CTO) PCI, addressing the following 12 areas: 1. Set-up for safe CTO PCI; 2. Guide catheter-–associated vessel injuries; 3. Hydraulic dissection, extraplaque haematoma expansion, and aortic dissections; 4. Haemodynamic collapse during CTO PCI; 5. Side branch occlusion; 6. Perforations; 7. Equipment entrapment; 8. Vascular access considerations; 9. Contrast-induced acute kidney injury; 10. Radiation injury; 11 When to stop; and, 12. Proctorship. This statement complements the global CTO crossing algorithm; by advising how to prevent and deal with complications, this statement aims to facilitate clinical practice, research, and education relating to CTO PCI. © 2024 The Author(s)	Chronic total occlusion; Consensus document; Global; Percutaneous coronary intervention; Safety		Philips; Asahi Intecc; Abbott Vascular; Boston Scientific Corporation, BSC; Terumo Medical Corporation; Abbott Laboratories; Bio-Excel; Orchestra Biomedical and Ostial Corporation; APT Medical and Teleflex	Funding text 1: Dr Jaber has received consultation fees and educational institutional grants from Medtronic, and Proctoring fees from Abbott, and has equity in Traverse Medical. Dr Jaffer has received sponsored research support from Canon, Siemens, Teleflex, Shockwave, Amarin, Mercator, and Boston Scientific; and is a consultant/speaker for Boston Scientific, Biotronik, Siemens, Magenta Medical, A	Elsevier Ltd	14439506		Article	Q2	722	6834	View
339	Hilmy F.; Dilogo I.H.; Reksodiputro M.H.; Antarianto R.D.; Al Mashur M.I.; Adhimulia K.J.	Hilmy, Fahresa (57925319600); Dilogo, Ismail Hadisoebroto (56161962800); Reksodiputro, Mirta Hediyati (35090488800); Antarianto, Radiana Dhewayani (57190862806); Al Mashur, Muslich Idris (57833530100); Adhimulia, Kevin Jonathan (57222107905)	57925319600; 56161962800; 35090488800; 57190862806; 57833530100; 57222107905	Evaluation of adipose-derived stem cells (ASCS) exosome implantation and platelet-rich fibrin (PRF) on critical long bone defects in Sprague-Dawley rats	2024	European Journal of Orthopaedic Surgery and Traumatology				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85194054694&doi=10.1007%2fs00590-024-03964-0&partnerID=40&md5=c1f75d5004ef442ea3727da1275bcde7	Department of Orthopaedic and Traumatology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Ear, Nose and Throat Clinic, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia	Hilmy F., Department of Orthopaedic and Traumatology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Dilogo I.H., Department of Orthopaedic and Traumatology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Reksodiputro M.H., Department of Ear, Nose and Throat Clinic, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Antarianto R.D., Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Al Mashur M.I., Department of Orthopaedic and Traumatology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Adhimulia K.J., Department of Orthopaedic and Traumatology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia	Introduction: This study aimed to assess the efficacy of adipose-derived mesenchymal stem cell exosomes (ASCs exosome) and platelet-rich fibrin (PRF) in treating critical long bone defects in Sprague-Dawley rats. Critical long bone defects, defined as exceeding 2 cm or 50% of the bone diameter, often pose a healing challenge. While autologous bone grafts have been considered, they have shown unreliable results and donor-site complications, necessitating alternative treatments. Methods: The research followed a quasi-experimental post-test only control group design involving 30 male Sprague-Dawley rats. The rats were divided into five groups and subjected to femur bone defect creation, internally fixed with a 1.4 mm K-wire, and treated with various combinations of hydroxyapatite (HA), bone graft (BG), ASCs exosome, and PRF. Histomorphometry and BMP-2 gene expression analysis were performed to evaluate bone healing. Results and Discussion: The results indicated that the group treated with HA + BG + ASCs exosome (group IV) exhibited the highest BMP-2 gene expression, while group III (HA + BG + ASCs exosome + PRF) had the highest chordin level. Overall, groups receiving ASCs exosome or PRF intervention showed elevated BMP-2 expression compared to the control group. The use of ASCs exosome and PRF showed comparable outcomes compared to bone graft administration in terms of histomorphometry analysis. Conclusion: The administration of adipose tissue derived mesenchymal stem cells and PRF has a comparable outcome with the use of bone graft in terms of osseus area and expression of BMP-2 in critical bone defect. © The Author(s) 2024.	Adipose-derived stem cells (ASCs) exosome; Critical long bone defect; Platelet-rich fibrin (PRF); Sprague-Dawley		PUTI Q1 University of Indonesia; Fakultas Kedokteran, Universitas Indonesia, FKUI, (PENG-006/UN2.RST/PPM.00.00/2022); Fakultas Kedokteran, Universitas Indonesia, FKUI	Funding text 1: This research was funded by a grant from the PUTI Q1 University of Indonesia based on the Letter of Research Grant from UI for the year 2022 (Batch 2) with reference number PENG-006/UN2.RST/PPM.00.00/2022. ; Funding text 2: Funding was provided by Fakultas Kedokteran, Universitas Indonesia (Grant no. PENG-006/UN2.RST/PPM.00.00/2022).	Springer Nature	16338065		Article	Q1	720	6864	View
342	Saleh I.; Hutami W.D.; Librianto D.; Prasetyo M.; Rahyussalim A.J.; Hendriarto A.; Noor E.A.; Rifki A.	Saleh, Ifran (57191511801); Hutami, Witantra Dhamar (57219938996); Librianto, Didik (57192894799); Prasetyo, Marcel (57192905252); Rahyussalim, Ahmad Jabir (59175656700); Hendriarto, Andra (57216821517); Noor, Erwin Ardian (57212582316); Rifki, Aliyya (59176047000)	57191511801; 57219938996; 57192894799; 57192905252; 59175656700; 57216821517; 57212582316; 59176047000	The Development of New Scoring System to Define the Presence of Instability and the Need of Fusion in Degenerative Lumbar Spinal Stenosis - Jakarta Instability Score	2024	Global Spine Journal				0	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196168529&doi=10.1177%2f21925682241262713&partnerID=40&md5=697fa2daa33fbc1c0afebb78df19b7e5	Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central Public Hospital, Dr, Jakarta, Indonesia; Department of Orthopaedic and Traumatology, Universitas Indonesia, Fatmawati Central General Hospital, Jakarta, Indonesia; Department of Radiology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, Indonesia	Saleh I., Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central Public Hospital, Dr, Jakarta, Indonesia; Hutami W.D., Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central Public Hospital, Dr, Jakarta, Indonesia; Librianto D., Department of Orthopaedic and Traumatology, Universitas Indonesia, Fatmawati Central General Hospital, Jakarta, Indonesia; Prasetyo M., Department of Radiology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, Indonesia; Rahyussalim A.J., Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central Public Hospital, Dr, Jakarta, Indonesia; Hendriarto A., Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Central Public Hospital, Dr, Jakarta, Indonesia; Noor E.A., Department of Orthopaedic and Traumatology, Universitas Indonesia, Fatmawati Central General Hospital, Jakarta, Indonesia; Rifki A., Department of Radiology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, Indonesia	Study Design: Systematic review, expert opinion and Delphi technique, and validity and reliability studies. Objective: We developed Jakarta Instability Score (JIS) to identify spinal instability and the need of fusion in degenerative lumbar spinal stenosis (LSS). Methods: This study consisted of systematic review to find predictors of spinal instability, expert opinion and modified Delphi technique to develop JIS, and validity and reliability studies of the newly developed JIS. Results: A total of 54 studies were included in the systematic reviews to obtain predictors of spinal instability. Through expert opinion and modified Delphi technique, JIS was developed and consisted of the clinical component (back pain), dynamic radiograph component (dynamic translation and angulation), and MRI component (facet joint effusion), each of the component would be scored, and the total scoring would be from 0 to 14. The final scoring would classify patients into three groups: stable group (score of 0 to 4) in which the fusion is not needed, potentially unstable group (score of 5 to 8) in which the decision of fusion is based on surgeon’s clinical judgment, and unstable group (score of 9 to 14) in which the fusion is needed. Final step of study concluded that this JIS had a high validity and reliability. Conclusion: The newly developed JIS was a valid and reliable scoring system that could help to identify the presence of instability in LSS and can be used as a guideline to decide whether spinal fusion will be needed. © The Author(s) 2024.	instability; lumbar spinal stenosis; scoring system; validity and reliability				SAGE Publications Ltd	21925682		Review	Q1	1043	3935	View

Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)